Synthetic MR Valuation Multiples

Synthetic MR Overview

About Synthetic MR

Synthetic MR AB develops software solutions for Magnetic Resonance Imaging that support shorter exam times and deliver more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a license agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.

Founded

2007

HQ

Employees

40

Website

syntheticmr.com

Sectors

Medical Imaging & DiagnosticsHealthcare SoftwareHealthTechB2B SaaSVertical SaaSLongevity

Financials (LTM)

Revenue: $7M

EBITDA: ($3M)

EV

$9M

Valuation Multiples

Multiples.vc

Start free trial

Synthetic MR Financials

Synthetic MR reported last 12-month revenue of $7M and negative EBITDA of ($3M).

In the same LTM period, Synthetic MR generated ($1M) in gross profit, ($3M) in EBITDA losses, and had net loss of ($5M).

Synthetic MR P&L

In the most recent fiscal year, Synthetic MR reported revenue of $6M and EBITDA of ($3M).

Synthetic MR expects next 12-month revenue of XXX and NTM EBITDA of XXX

Synthetic MR Stock Performance

Synthetic MR has current market cap of $10M, and enterprise value of $9M.

Synthetic MR's stock price is $0.11.

Synthetic MR Valuation Multiples

Synthetic MR trades at 1.4x EV/Revenue multiple, and (3.4x) EV/EBITDA.

Synthetic MR Financial Valuation Multiples

As of April 19, 2026, Synthetic MR has market cap of $10M and EV of $9M.

Equity research analysts estimate Synthetic MR's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Synthetic MR has a P/E ratio of (2.1x).

Synthetic MR Margins & Growth Rates

Synthetic MR's revenue in the last 12 month grew by 16%.

Synthetic MR's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.3M for the same period.

Synthetic MR's rule of 40 is 3% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Synthetic MR's rule of X is 25% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Synthetic MR Public Comps

See public comps and valuation multiples for other Medical Imaging & Diagnostics and Healthcare Software comps.

Synthetic MR M&A Activity

Synthetic MR acquired XXX companies to date.

Last acquisition by Synthetic MR was on XXXXXXXX, XXXXX. Synthetic MR acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Synthetic MR Investment Activity

Synthetic MR invested in XXX companies to date.

Synthetic MR made its latest investment on XXXXXXXX, XXXXX. Synthetic MR invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).